Accessibility Menu
WuXi AppTec logo

WuXi AppTec(OTC) WUXAY

Current Price$20.05
Market Cap$9.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+16%
5 Year+10%
1 Year+66%
1 Month+12%
WuXi AppTec last closing stock price
MetricPriceDate
Last closeUSD 20.052026-07-24
WuXi AppTec stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.66%USD 19.532026-07-17
1 month+11.94%USD 17.912026-06-24
3 month+31.01%USD 15.302026-04-24
Year to date+61.03%USD 12.452025-12-31
1 year+65.63%USD 12.102025-07-24
3 year+138.63%USD 8.402023-07-25
5 year+10.24%USD 18.192021-07-14
Since inception+15.92%USD 17.302021-02-24

WuXi AppTec Financials at a Glance

Market Cap

$9.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥48.16B

Net Income (TTM)

CN¥20.11B

EPS (TTM)

$0.96

P/E Ratio

20.31

Dividend

$0.23

Beta (Volatility)

0.56 (Low)

Price

$20.05

Volume

1,843

Open

$20.18

Previous Close

$20.05

Daily Range

$20.05 - $20.18

52-Week Range

$12.45 - $21.35

Estimated Earnings Date

Jul 27, 2026

WUXAY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi AppTec

WuXi AppTec Co., Ltd. is a leading global provider of research, development, and manufacturing services for the pharmaceutical and biotechnology industries. The company operates across multiple regions, including China, the United States, and Europe, facilitating the advancement of small molecule pharmaceuticals and cell and gene therapies.

Products and Services
  • Comprehensive contract research and manufacturing services
  • Biological services from target identification to clinical trials
  • Accelerated solutions for cell and gene therapies
Growth Outlook
  • Revenue growth of 24% year-over-year in the latest quarter
  • Strong demand for CRDMO services driving expansion
  • Investment in R&D to enhance service offerings and capabilities
Financial Highlights
  • Net income of CNY 4.65 billion in the latest quarter
  • Operating income margin of 45% reflects operational efficiency
  • Current ratio of 3.42 indicates strong liquidity position
WuXi AppTec Co., Ltd. has established itself as a vital player in the healthcare sector, particularly in the medical diagnostics and research industry. The company's diverse service offerings cater to a wide range of clients, from small biotech firms to large pharmaceutical companies. The recent financial performance showcases robust growth, with a significant increase in revenue and net income, indicating strong operational capabilities and market demand. The company's focus on research and development positions it well for future growth, as it continues to innovate and expand its service offerings. With a solid liquidity position and efficient operational margins, WuXi AppTec presents a compelling opportunity for potential investors interested in the healthcare sector.
AI Generated • Jul 26, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

33,834

CEO

Min Zhang Chen, PhD; Ge Li, PhD; Qing Yang

Website

www.wuxiapptec.com.cn

Headquarters

Shanghai, SH 200131, CN

WUXAY Financials

Key Financial Metrics (TTM)

Gross Margin

49.24%

Operating Margin

42.66%

Net Income Margin

41.74%

Return on Equity

27.31%

Return on Capital

19.33%

Return on Assets

18.74%

Earnings Yield

4.92%

Dividend Yield

1.15%

Payout Ratio

29.56%

Stock Overview

Market Cap

$9.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

463.51M

Volume

1.84K

Avg. Volume

1.90K

Financials (TTM)

Gross Profit

CN¥23.73B

Operating Income

CN¥20.83B

EBITDA

CN¥25.29B

Operating Cash Flow

CN¥24.95B

Capital Expenditure

-CN¥5.98B

Free Cash Flow

CN¥18.97B

Cash & ST Invst.

CN¥43.38B

Total Debt

CN¥8.21B

WuXi AppTec Performance Analysis

WuXi AppTec annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 5,844,425,23464.6%
20232023-12-31CNY 5,459,126,439-6.6%
20242024-12-31CNY 4,969,799,070-9.0%
20252025-12-31CNY 6,040,359,96221.5%
WuXi AppTec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3015.4%
Q32025-09-307.5%
Q42025-12-315.2%
Q12026-03-31-1.3%
WuXi AppTec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.4255.7%
20232023-12-31CNY 0.5122.2%
20242024-12-31CNY 0.45-12.4%
20252025-12-31CNY 0.92104.7%
WuXi AppTec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3032.8%
Q32025-09-30-28.8%
Q42025-12-31104.1%
Q12026-03-31-36.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CN¥12.44B

+28.8%

Gross Profit

CN¥6.27B

+53.6%

Gross Margin

50.40%

N/A

Market Cap

$9.29BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$274.67K

N/A

Employees

33,834

N/A

Net Income

CN¥4.65B

+26.7%

EBITDA

CN¥5.64B

+29.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CN¥43.38B

+68.5%

Total Debt

CN¥8.21B

+32.9%

Accounts Receivable

CN¥8.58B

-2.3%

Inventory

CN¥9.97B

+53.5%

Long Term Debt

CN¥2.24B

+61.0%

Short Term Debt

CN¥5.98B

+24.7%

Return on Assets

18.74%

N/A

Return on Invested Capital

23.28%

N/A

Free Cash Flow

CN¥2.40B

-2.4%

Operating Cash Flow

CN¥3.60B

+12.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RSMDFResMed Inc.
$16.72+0.00%
DSKYFDaiichi Sankyo Company, Limited
$15.95-8.96%
FSNUFFresenius SE & Co. KGaA
$54.35+0.00%
DSNKYDaiichi Sankyo Company, Limited
$17.25+1.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
FFord Motor Company
$14.37+0.02%
AALAmerican Airlines Group
$14.48+0.07%

Questions About WUXAY

What is the current price of WuXi AppTec?

WuXi AppTec is trading at $20.05 per share.

What is the 52-week range for WuXi AppTec?

Over the past 52 weeks, WuXi AppTec has traded between $12.45 and $21.35.

How much debt does WuXi AppTec have?

As of the most recent reporting period, WuXi AppTec reported total debt of CN¥1.21B.

How much cash does WuXi AppTec have on hand?

WuXi AppTec reported CN¥3.97B in cash and cash equivalents in its most recent financial results.

What is WuXi AppTec’s dividend yield?

WuXi AppTec currently has a dividend yield of 1.15%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services